BMS Sees Zeposia As Safer Oral Option In Ulcerative Colitis

Efficacy Comparable To Gilead/Galapagos JAK Inhibitor Filgotinib

 
• By Mandy Jackson
Medical Concept: Ulcerative Colitis on Black Chalkboard. Medical Concept: Ulcerative Colitis - Black Chalkboard with Hand Drawn Text and Red Stethoscope. Top View. 3D Rendering.
Zeposia could be the first S1P receptor modulator approved for UC • Source: Shutterstock

More from Clinical Trials

More from R&D